The Signatera test can be performed on all solid tumours. Please consult with our colleagues about your results!

The most common tumour types where Signatera is already routinely used are:

Breast cancer

Colon cancer

Lung cancer

Pancreatic cancer

Stomach cancer

Esophageal cancer

Ovarian cancer

Endometrial tumour

Neuroendocrine tumours

Melanoma

Sarcoma

Kidney cancer

The Signatera test cannot be used in the following cases:

In synchronous primary tumours*

In case of pregnancy

In patients who have had a previous (non-autologous) bone marrow transplant

In patients who have had a blood transfusion in the last 3 months

In non-solid tumours, eg.: haematological malignancies

For brain tumors

* Inquire from our colleagues

Please enter your personal details and send us your questions, and our experts will be happy to answer within 24 - 48 hours.

Thank your for your message. We will contact you in 24-48 hours.
Error. Please try again.